OncoLize develops injectable drug depots that deliver chemo drugs and novel drugs directly into the tumor mass, and keep it where it should be.

We will show recent preclinical successes run by Leiden University Medical Centre using standard-of-care Gemcitabine in PDAC models.

We will also highlight our upcoming clinical trials with a EU-consortium led by Amsterdam University Medical Centre.